Boy, what a week. As I sat down to write my first weekly recap of healthcare news this year, it took me a moment to remember that anything happened before Wednesday, when a mob of pro-Trump rioters stormed the Capitol.
Before I jump in: I wanted to introduce you all to Patricia Kelly Yeo, who joins us as a fellow on the healthcare team! She’ll be helping us cover the wide world of the healthcare industry as it continues to grapple with the pandemic. Find her on email at [email protected] and on Twitter at @patkyeo.
Shelby looked through state data as well, and found that among the shots that are being distributed, most are going to white people. That stands in contrast with the pandemic, which has disproportionately hit communities of color.
More shots from other drugmakers are on their way. We'll likely get data from Johnson & Johnson's vaccine in January, and an authorization could come in February.
Andrew has the full timeline of what to expect from COVID-19 vaccines in 2021.
I remember the buzz in the Business Insider newsroom the morning in January 2018 that Amazon, Berkshire Hathaway, and JPMorgan announced plans for a joint health venture.
Pulling together her own reporting - as well as great reporting from a number of other outlets - Blake pieced together an inside look at Haven's downfall, and how it was set up for failure.
Finally, with the help of Pitchbook, Megan rounded up the digital health startups that reached "unicorn" status in 2020, putting them on our radars to keep a close eye on in 2021.
We'll be tuning into the J.P. Morgan Healthcare Conference next week. I for one will be curious to see how one of the biggest events in the healthcare industry unfolds virtually.
What are you expecting to hear coming out of the conference? How are you marking the occasion, if not with sprints up and down San Francisco's hills? Let me know at [email protected], and you can reach the entire healthcare team at [email protected].
